Browse studies
Find your next paid study
15 recruiting studies matching your filters
Phase 1
Phase 1/2 Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Assessment of the safety and efficacy of HLD-0915 as monotherapy in patients with metastatic castration resistant prostate cancer (mCRPC) that have progressed …
Prostate Cancer Metastatic DiseaseProstate Cancer (Adenocarcinoma)
Halda Therapeutics OpCo, Inc.NCT06800313
Phase 2
Phase II Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
To determine if dexamethasone or dexamethasone plus metronidazole restore sensitivity to abiraterone for the treatment of metastatic prostate cancer.
Prostate Cancer (Adenocarcinoma)Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT06616597
Phase 3
A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
This study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual comb…
Prostate Cancer (Adenocarcinoma)
Canadian Cancer Trials GroupNCT06592924